{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:31Z","timestamp":1759336171886,"version":"3.41.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development (CNPq, Brazil","doi-asserted-by":"publisher","award":["466796\/2014-5"],"award-info":[{"award-number":["466796\/2014-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuropharm.2017.05.025","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T15:46:17Z","timestamp":1496072777000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through \u03bc-opioid and B2-kinin receptors"],"prefix":"10.1016","volume":"123","author":[{"given":"Caio C\u00e9sar","family":"Sestile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhonatan Christian","family":"Maraschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Scalco","family":"Gama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"H\u00e9lio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederico Guilherme","family":"Graeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Aparecida","family":"Audi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.05.025_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF01972410","article-title":"Changes in rectal temperature of the rabbit by intracerebroventricular injection of bradykinin and related kinins","volume":"8","author":"Almeida e Silva","year":"1978","journal-title":"Agents Actions"},{"year":"1997","series-title":"Discovery of Bradykinin and the Kallikrein-kinin system","author":"Beraldo","key":"10.1016\/j.neuropharm.2017.05.025_bib2"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00058-4","article-title":"Bioregulation of kinins: kallikreins, kininogens, and kininases","volume":"44","author":"Bhoola","year":"1992","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1734-1140(13)71082-X","article-title":"Dose-depending effect of intracerebroventricularly administered bradykinin on nociception in rats","volume":"65","author":"Bujalska-Zadro\u017cny","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0031-9384(92)90325-V","article-title":"Opioid mediation of the antiaversive and hyperalgesic actions of bradykinin injected into the dorsal periaqueductal gray of the rat","volume":"52","author":"Burdin","year":"1992","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0006-2952(69)90235-4","article-title":"Subcellular distribution and properties of the bradykinin inactivation system in rabbit brain homogenates","volume":"18","author":"Camargo","year":"1969","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/ALN.0b013e318242b2ea","article-title":"Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors","volume":"116","author":"Cayla","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib8","first-page":"222","article-title":"On possible central effects of bradykinin in the cat","volume":"9","author":"Corrado","year":"1960","journal-title":"Acta Physiol. Latinoamer"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0028-3908(74)90008-2","article-title":"Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanaesthetized rat","volume":"13","author":"Correa","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-3565(25)30108-4","article-title":"Central site of the hypertensive action of bradykinin","volume":"192","author":"Corr\u00eaa","year":"1975","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib11","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1073\/pnas.76.3.1489","article-title":"Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain","volume":"76","author":"Corr\u00eaa","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2007.08.003","article-title":"Participation of kallikrein\u2013kinin system in different pathologies","volume":"8","author":"Costa-Neto","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.HYP.17.4.589","article-title":"History of the design of captopril and related inhibitors of angiotensin converting enzyme","volume":"17","author":"Cushman","year":"1991","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0014-2999(71)90171-3","article-title":"Catatonia induced in the rabbit by intracerebral injection of bradykinin and morphine","volume":"15","author":"da Silva","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.npep.2006.12.007","article-title":"Bradykinin into amygdala induces thermal hyperalgesia in rats","volume":"41","author":"Dalmolin","year":"2007","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1113\/jphysiol.1960.sp006548","article-title":"Actions of pure bradykinin","volume":"153","author":"Elliott","year":"1960","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1096\/fj.06-0602ufm","article-title":"The ACE and I: how ACE inhibitors came to be","volume":"20","author":"Erdos","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","article-title":"A\u00a0bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararaca","volume":"24","author":"Ferreira","year":"1965","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib19","first-page":"1000","article-title":"Localization of central pressor action of bradykinin in medulla oblongata","volume":"265","author":"Fior","year":"1993","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib21","first-page":"465","article-title":"Kinin as possible neurotransmitters in the central nervous system","volume":"23","author":"Graeff","year":"1971","journal-title":"Cienc. Cult."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1969.tb08511.x","article-title":"Behavioural and somatic effects of bradykinin injected into the cerebral ventricles of unanaesthetized rabbits","volume":"37","author":"Graeff","year":"1969","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/14737175.5.2.259","article-title":"Management of panic disorder","volume":"5","author":"Lader","year":"2005","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1476-5381.1989.tb12014.x","article-title":"Central nervous system kinin receptors and the hypertensive response mediated by bradykinin","volume":"97","author":"Lindsey","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)30116-3","article-title":"Effect of intracerebroventricular bradykinin and related peptides on rabbit operant behavior","volume":"193","author":"Melo","year":"1975","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-013-1610-1","article-title":"Modeling panic disorder in rodents","volume":"354","author":"Moreira","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3727\/096368915X687778","article-title":"Roles of kinins in the nervous system","volume":"24","author":"Negraes","year":"2015","journal-title":"Cell Transpl."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1471-4159.1990.tb03113.x","article-title":"Localization of endo-oligopeptidase (EC 3.4.22.19) in the rat nervous tissue","volume":"55","author":"Oliveira","year":"1990","journal-title":"J.\u00a0Neurochem."},{"year":"2005","series-title":"The Rat Brain in Stereotaxic Coordinates \u2013 The New Coronal Set","author":"Paxinos","key":"10.1016\/j.neuropharm.2017.05.025_bib49"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1476-5381.1996.tb15564.x","article-title":"Central B2 receptor involvement in the antinociceptive effect of bradykinin in rats","volume":"118","author":"Pel\u00e1","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-4159.1984.tb12846.x","article-title":"Identification of bradykinin in mammalian brain","volume":"43","author":"Perry","year":"1984","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1152\/physrev.00048.2010","article-title":"Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors","volume":"92","author":"Petho","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0163-7258(98)00011-4","article-title":"Pathophysiology of the kallikrein-kinin system in mammalian nervous tissue","volume":"79","author":"Raidoo","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0269881114554274","article-title":"Interaction between \u03bc-opioid and 5-HT1A receptors in the regulation of panic-related defensive responses in the rat dorsal periaqueductal grey","volume":"28","author":"Rangel","year":"2014","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/02656738809029308","article-title":"Hyperthermic effect of centrally administered bradykinin in the rat: role of prostaglandins and serotonin","volume":"4","author":"Rao","year":"1988","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0028-3908(71)90087-6","article-title":"Antinociceptive action of intraventricular bradykinin","volume":"10","author":"Ribeiro","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1476-5381.1973.tb08183.x","article-title":"Antinociceptive action of bradykinin and related kinins of larger molecular weights by the intraventricular route","volume":"47","author":"Ribeiro","year":"1973","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/ajplegacy.1949.156.2.261","article-title":"Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin","volume":"156","author":"Rocha e Silva","year":"1949","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-3565(25)26881-1","article-title":"Release of antidiuretic hormone by bradykinin","volume":"146","author":"Rocha e Silva","year":"1964","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881113485144","article-title":"Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and -receptors","volume":"27","author":"Roncon","year":"2013","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.neuropharm.2015.08.037","article-title":"Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter \u03bc-opioid receptors","volume":"99","author":"Roncon","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10571-011-9754-6","article-title":"Angiotensin II AT1 receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders","volume":"32","author":"Saavedra","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"Schenberg","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.109.152678","article-title":"The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity","volume":"330","author":"Sirohi","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40256-016-0173-4","article-title":"Unraveling the pivotal role of bradykinin in ACE inhibitor activity","volume":"16","author":"Taddei","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0162-3109(96)00069-0","article-title":"Development of hyperthermia and hyperalgesia following intracerebroventricular administration of endotoxin in the rat: effect of kinin B1 and B2 receptor antagonists","volume":"33","author":"Walker","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib50","series-title":"International, Guiding Principles for Biomedical Research Involving Animals","article-title":"International, guiding principles for biomedical research involving animals","author":"WHO. Ethical Issues Scientific and Ethical Review Group (SERG)","year":"1985"},{"key":"10.1016\/j.neuropharm.2017.05.025_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neubiorev.2014.03.007","article-title":"Serotonin in anxiety and panic: contributions of the elevated T-maze","volume":"46","author":"Zangrossi","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2017.05.025_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2015.05.077","article-title":"DAMGO depresses inhibitory synaptic transmission via different downstream pathways of \u03bc opioid receptors in ventral tegmental area and periaqueductal gray","volume":"301","author":"Zhang","year":"2015","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:54:36Z","timestamp":1750280076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817302502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"alternative-id":["S0028390817302502"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.05.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through \u03bc-opioid and B2-kinin receptors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}